Although the AFP test has been found to be relatively insensitive for detecting HCC in general (Trevisani et al, 2001), it has the substantial advantage that its sensitivity is only weakly correlated with tumour size, meaning that it should be a valuable aid to the detection of some of the smallest, most easily treated tumours. This evidence concerns the gene AFP and hepatocellular carcinoma.